Three new #obesity drugshigh dose semaglutide, semaglutide plus cagrilintide, and oral orforglipronmay soon be approved in the US. JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin examine how cagrisema #semaglutide #amylin #glp1 #obesity #dualincretins Yulia Lurye, MD PDF] Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial. Semantic Scholar Weight Loss Efficacy of Cagrilintide and Semaglutide gutsandgrowth Unlocking the Power of Cagrilintide: A Deep Dive Into Dosage Schedules and What to Expect Feast